GeminIQ Website Logo

Viewing OGN free

Subscribe for full history, 90+ metrics, screener, watchlist...

Organon & Co.

OGN

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
1,1321,116574672599547675763704575693414
Accounts Receivable Net Current
1,4921,3841,3311,4841,4841,4571,3581,6851,6171,5471,7441,648
Inventory Net
1,3511,3731,4061,4881,4541,3621,3211,3831,2871,2631,3151,186
Other Assets Current
1,1361,0591,0331,0561,0811,005994925901811756802
Assets Of Disposal Group Including Discontinued Op…
008---0-----
Assets Current
5,1114,9324,3524,7004,6184,3714,3484,7564,5094,1964,5084,050
Property Plant And Equipment Net
1,2811,2791,3031,2901,2661,1971,1681,2041,1621,1801,1831,096
Goodwill
4,1534,1534,1534,6804,6804,6804,6804,6034,6034,6034,6034,603
Finite Lived Intangible Assets Net
1,1121,0991,1301,3401,3621,4171,414763684718533561
Deferred Income Taxes And Other Assets Noncurrent
1,5211,5331,5391,5421,5741,4911,4911,4261,1961,1941,231702
Disposal Group Including Discontinued Operation As…
00390---0-----
Assets
13,17812,99612,86713,55213,50013,15613,10112,75212,15411,89112,05811,012
Long Term Debt Current
-----2020109998
Liabilities And Stockhold…
Liabilities Current
Debt Current
74161645115-20-----
Accounts Payable Current
1,0519839521,0741,0671,0061,1531,0921,2439551,3141,067
Accrued Income Taxes Current
847785116194176134230201196206161
Liabilities Of Disposal Group Including Discontinu…
002---0-----
Liabilities Current
2,6162,5002,3902,6792,7962,6152,7182,7902,7552,5452,9182,491
Long Term Debt Noncurrent
8,4798,5538,6288,7838,7818,9368,8608,7398,6478,7058,7518,646
Deferred Income Tax Liabilities Net
515657626969745660444743
Other Liabilities Noncurrent
1,0269841,0081,1221,121994977674548549412421
Liabilities Of Disposal Group Including Discontinu…
0032---0-----
Liabilities
12,17212,09312,11512,64612,76712,61412,62912,25912,01011,84312,12811,601
Stockholders Equity
Common Stock Value
333333333333
Additional Paid In Capital Common Stock
19918616715913913010886634925-
Retained Earnings Accumulated Deficit
1,3521,2531,1091,3181,1631,0261,010975690573443-16
Accumulated Other Comprehensive Income Loss Net Of…
-548-539-527-574-572-617-649-571-612-577-541-576
Stockholders Equity
1,00690375290673354247249314448-70-589
Liabilities And Stockholders Equity
13,17812,99612,86713,55213,50013,15613,10112,75212,15411,89112,05811,012
Allowance For Doubtful Accounts Receivable Current
1314121212121413101199
Inventory Noncurrent
27325223624724020721513011310111095
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
500500500500500500500500500500500500
Common Stock Shares Issued
263263260260260258258258257256256256
Shares Outstanding
263263260260260258258258257256256256

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20260.75%1.96%2.11%---------
2025-9.18%1.90%-1.13%8.26%17.34%5.27%-7.14%-5.84%11.06%-25.92%19.90%64.87%
20248.52%7.74%8.47%18.97%2.10%-8.66%-13.94%-17.88%-11.35%3.22%-25.42%-39.23%
2023----3.22%-24.11%-34.60%-12.44%7.22%19.47%0.74%0.96%25.22%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.95
1.97
1.82
1.75
1.65
1.67
1.60
1.70
1.64
1.65
1.54
1.63
Quick Ratio
1.44
1.42
1.23
1.20
1.13
1.15
1.11
1.21
1.17
1.15
1.09
1.15
Working Capital
2.50B
2.43B
1.96B
2.02B
1.82B
1.76B
1.63B
1.97B
1.75B
1.65B
1.59B
1.56B
Leverage & Debt
Debt to Equity
12.10
13.39
16.11
13.96
17.42
23.27
26.76
24.87
83.40
246.73
-173.26
-19.70
Interest Coverage TTM
2.05
2.09
1.84
2.36
2.30
2.31
2.55
2.51
2.25
2.28
2.28
2.32
Debt Ratio
0.92
0.93
0.94
0.93
0.95
0.96
0.96
0.96
0.99
1.00
1.01
1.05
Efficiency & Turnover
Asset Turnover TTM
0.46
0.47
0.48
0.48
0.49
0.50
0.51
0.54
0.55
0.56
0.54
0.57
Days Sales Outstanding TTM
88.64
84.13
78.95
91.79
90.10
87.10
88.41
94.91
94.59
86.03
93.80
91.64
Receivables Turnover TTM
4.12
4.34
4.62
3.98
4.05
4.19
4.13
3.85
3.86
4.24
3.89
3.98
Per Share Metrics
Diluted EPS TTM
0.77
0.94
0.72
1.92
2.69
2.87
3.33
5.01
3.87
4.05
3.99
2.28
Free Cash Flow Per Share TTM
2.16
2.62
2.07
2.99
2.53
3.01
2.97
2.90
3.32
1.99
2.15
1.70
Dividend Per Share TTM
0.07
0.08
0.34
0.61
0.88
1.16
1.16
1.15
1.15
1.14
1.15
1.15
Margin Metrics
Gross Profit Margin TTM
52.68%
52.82%
53.30%
55.04%
56.26%
57.18%
58.02%
73.21%
73.68%
74.13%
75.14%
60.55%
Operating Profit Margin TTM
8.01%
8.71%
6.84%
11.14%
10.60%
10.68%
12.60%
12.20%
10.32%
10.62%
10.75%
11.06%
Net Profit Margin TTM
3.41%
3.99%
3.01%
7.95%
11.14%
11.92%
13.49%
20.30%
15.76%
16.50%
16.33%
9.51%
Growth Metrics
Net Revenue Growth (1Y)
-2.45%
-2.08%
-2.92%
-1.69%
-1.02%
-0.84%
2.24%
4.21%
2.89%
3.29%
1.44%
-2.26%
Net Income Growth (1Y)
-70.14%
-67.20%
-78.36%
-61.49%
-30.00%
-28.37%
-15.54%
122.39%
32.63%
40.35%
11.56%
-42.14%
EPS Growth (1Y)
-70.45%
-67.52%
-78.56%
-61.86%
-30.71%
-28.97%
-16.14%
120.74%
31.62%
39.63%
11.05%
-42.42%
Valuation Metrics
P/E TTM
16.99
6.32
9.90
5.50
3.56
5.06
4.30
3.61
5.00
4.26
3.28
6.75
P/B TTM
3.53
1.72
2.46
3.04
3.40
7.00
7.88
9.52
34.75
92.81
-47.99
-6.71
P/S TTM
0.58
0.25
0.30
0.44
0.40
0.60
0.58
0.73
0.79
0.70
0.54
0.64
Market Cap
3.55B
1.56B
1.85B
2.75B
2.49B
3.79B
3.72B
4.69B
5.00B
4.46B
3.36B
3.95B
Enterprise Value
10.97B
9.01B
9.92B
10.91B
10.79B
12.20B
11.92B
12.68B
12.96B
12.59B
11.43B
12.19B
Calculated Values
Free Cash Flow TTM
567.00M
683.00M
538.00M
777.00M
658.00M
777.00M
764.00M
747.00M
854.00M
510.00M
548.00M
434.00M
Net Debt
7.42B
7.45B
8.07B
8.16B
8.30B
8.41B
8.21B
7.99B
7.95B
8.14B
8.07B
8.24B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-06Sale
Owner: Holzbaur, Lynette
Title: SVP and Corporate Controller
Shares: 26,448
Price/Share: $13.35
Value: $353,085.74
Shares Owned: -
Relationship: Officer
Ownership: Direct
2026-05-06Purchase
Owner: Holzbaur, Lynette
Title: SVP and Corporate Controller
Shares: 26,448
Price/Share: $13.35
Value: $353,085.74
Shares Owned: 52,851
Relationship: Officer
Ownership: Direct
2025-11-12Purchase
Owner: Cox, Carrie Smith
Title: Executive Chair
Shares: 65,400
Price/Share: $7.67
Value: $501,618.00
Shares Owned: 77,869
Relationship: Director,Officer
Ownership: Indirect
2025-05-14Purchase
Owner: Cox, Carrie Smith
Title: -
Shares: 12,469
Price/Share: $8.07
Value: $100,624.83
Shares Owned: 12,469
Relationship: Director
Ownership: Direct
2025-05-07Purchase
Owner: Falcione, Aaron
Title: Chief Human Resources Officer
Shares: 5,500
Price/Share: $8.77
Value: $48,235.00
Shares Owned: 62,974
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
72.59%
Inst. Shares: 188,994,445
Shares Outstanding: 260,370,000
2025-12-31
72.10%
Inst. Shares: 187,107,605
Shares Outstanding: 259,495,000
2025-09-30
72.42%
Inst. Shares: 188,269,456
Shares Outstanding: 259,975,000
2025-06-30
77.39%
Inst. Shares: 201,154,871
Shares Outstanding: 259,939,000
2025-03-31
72.74%
Inst. Shares: 187,558,722
Shares Outstanding: 257,862,000

Organon & Co. (OGN) — SEC Financial Statements & Analysis

Organon & Co. (OGN) is a pharmaceutical preparations company. Organon & Co. trades on NYSE as: OGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Organon & Co. reported a -2.45% year-over-year revenue growth, a Gross Profit Margin of 52.68% (TTM), a Debt-to-Equity ratio of 12.10x, a Price-to-Sales (P/S) ratio of 0.58x (TTM), a Price-to-Book (P/B) ratio of 3.53x (TTM), at a market cap of $3.55B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-2.45%
Gross Profit Margin TTM
52.68%
Debt To Equity
12.10x
P/S TTM
0.58x
P/B TTM
3.53x
Market Cap
$3.55B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Organon & Co. in?

Organon & Co. (OGN) operates in the Pharmaceutical Preparations industry.

What is OGN's market cap?

Organon & Co. (OGN) has a market capitalization of $3.55B as of 2026-06-30.

What is OGN's P/E ratio?

Organon & Co. (OGN)'s trailing twelve month P/E ratio is 16.99x as of 2026-06-30.

What exchange does OGN trade on?

Organon & Co. (OGN) trades on the NYSE.

Wall Street's data.
Main Street's price.